|
Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study. |
|
|
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi |
Speakers' Bureau - Astellas Pharma; Ferring; Janssen Oncology; Pierre Fabre; Sanofi |
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Janssen; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbott Laboratories |
|
Travel, Accommodations, Expenses - European Association of Urology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |